For instance, in vivo homophilic CD44-mediated CTC clustering of metastatic breast cancer cells in mice was largely inhibited by the administration of anti-CD44 neutralizing antibody, leading to decreased metastatic capacity (Liu et al., 2019). This evidence concerns the gene CD44 and breast carcinoma.